Okamura Kohji, Sakaguchi Hironari, Sakamoto-Abutani Rie, Nakanishi Mahito, Nishimura Ken, Yamazaki-Inoue Mayu, Ohtaka Manami, Periasamy Vaiyapuri Subbarayan, Alshatwi Ali Abdullah, Higuchi Akon, Hanaoka Kazunori, Nakabayashi Kazuhiko, Takada Shuji, Hata Kenichiro, Toyoda Masashi, Umezawa Akihiro
Department of Systems BioMedicine, National Research Institute for Child Health and Development, Tokyo, 157-8535, Japan.
Department of Reproduction, National Research Institute for Child Health and Development, Tokyo, 157-8535, Japan.
Sci Rep. 2016 May 20;6:26342. doi: 10.1038/srep26342.
Disease-specific induced pluripotent stem cells (iPSCs) have been used as a model to analyze pathogenesis of disease. In this study, we generated iPSCs derived from a fibroblastic cell line of xeroderma pigmentosum (XP) group A (XPA-iPSCs), a rare autosomal recessive hereditary disease in which patients develop skin cancer in the areas of skin exposed to sunlight. XPA-iPSCs exhibited hypersensitivity to ultraviolet exposure and accumulation of single-nucleotide substitutions when compared with ataxia telangiectasia-derived iPSCs that were established in a previous study. However, XPA-iPSCs did not show any chromosomal instability in vitro, i.e. intact chromosomes were maintained. The results were mutually compensating for examining two major sources of mutations, nucleotide excision repair deficiency and double-strand break repair deficiency. Like XP patients, XPA-iPSCs accumulated single-nucleotide substitutions that are associated with malignant melanoma, a manifestation of XP. These results indicate that XPA-iPSCs may serve a monitoring tool (analogous to the Ames test but using mammalian cells) to measure single-nucleotide alterations, and may be a good model to clarify pathogenesis of XP. In addition, XPA-iPSCs may allow us to facilitate development of drugs that delay genetic alteration and decrease hypersensitivity to ultraviolet for therapeutic applications.
疾病特异性诱导多能干细胞(iPSC)已被用作分析疾病发病机制的模型。在本研究中,我们从A型着色性干皮病(XP)的成纤维细胞系中生成了iPSC(XPA-iPSC),XP是一种罕见的常染色体隐性遗传病,患者在暴露于阳光的皮肤区域会发生皮肤癌。与先前研究中建立的共济失调毛细血管扩张症衍生的iPSC相比,XPA-iPSC对紫外线暴露表现出超敏反应,并且单核苷酸取代会积累。然而,XPA-iPSC在体外未显示出任何染色体不稳定性,即染色体保持完整。这些结果相互补充,用于研究两种主要的突变来源,核苷酸切除修复缺陷和双链断裂修复缺陷。与XP患者一样,XPA-iPSC积累了与恶性黑色素瘤相关的单核苷酸取代,这是XP的一种表现。这些结果表明,XPA-iPSC可作为一种监测工具(类似于艾姆斯试验,但使用哺乳动物细胞)来测量单核苷酸改变,并且可能是阐明XP发病机制的良好模型。此外,XPA-iPSC可能使我们能够促进开发延迟基因改变并降低对紫外线超敏反应的药物,用于治疗应用。